ARCHIVES

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: New NIH Grant Program Offers Up To $1 Million a Year For Centers At Minority Institutions

January 25, 1985

NCI Agrees To give NSABP One Year Until Competition; Advisors OK Concept

June 17, 1994

ACS Funds $54 Million in Grants

June 28, 2002

Fewer, Larger RT Doses Cut Recurrence Of Early Breast Cancer, UK Study Finds

June 29, 2007

IOM Report: Seek More Comment From Public On Priorities, NIH Told

July 17, 1998

Program Announcement For Clinical Research

February 29, 1980